Updated USPSTF Cervical Cancer Screening Recommendations: 2018

Substantial changes from 2012 center on the addition of HPV testing.

Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF)

Target Audience: Women's healthcare providers

Background

During the past decade, cervical human papillomavirus (HPV) testing has been shown to be at least as sensitive as cytological testing for detecting precancerous lesions. Accordingly, the USPSTF has updated their recommendations for cervical cancer screening. Current recommendations for asymptomatic women who are not immunocompromised are as follows:

Recommendations

Women aged 21 to 29 should be screened every 3 years with cytology alone.
Women aged 30 to 65 should be screened every 3 years with cervical cytology alone, every 5 years with HPV testing alone, or every 5 years with cervical cytology plus HPV (cotesting).
Women…

Reviewing Author

Anna Wald, MD, MPH

Disclosures

Consultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)

RoyaltiesUpToDate

Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris

Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases

Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)